medicines transparency alliance16/12/2015 pricing: observations nazeem mohamed chairman, uganda...

7
Medicines Transparency Alliance 21/07/22 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O. Kampala Pharmaceutical Industries (1996) Ltd

Upload: cleopatra-dorsey

Post on 21-Jan-2016

224 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance21/04/23

Pricing: Observations

Nazeem MohamedChairman, Uganda Pharmaceutical Manufacturers Association (UPMA)C.E.O. Kampala Pharmaceutical Industries (1996) Ltd

Page 2: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance

Pricing: Information/Data Gathering

Robust methodologies and publications exist (WHO/HAI) on pricing of medicines

Share data across countries on “public procurement” as means to increase efficiency

Data must be shared across multi-sectors before policies are finalised – Transparency is the key!!

Pricing/Affordability must go hand in hand

Convert prices into a Availability Index (no’s days wages to pay for treatment)

A finding may have many causes!!

Information must be dynamic and communicated!!!

21/04/23

Page 3: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance

Pricing: Policy

Pricing is only one aspect of the “access” issue and there is NO one answer!!

Effective policy will have to be a package of measures addressing pricing, e.g.– Generic substitution– Price/margin controls– Procurement efficiency– Differential pricing– Support local manufacturing– Increase public sector availability

Need for a financing mechanism for the poor and even the near poor

Must measure the impact of policy and be prepared to adjust as necessary

21/04/23

Page 4: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance

Pricing: Issues

Watch for unwanted negative effects– Price controls may impact on availability– Growth of cheaper sub standard products

Asymmetric information, i.e. Choice of medicine not made by the end consumer!!

Consider the impact of “Chronic diseases” when developing policy (priorities!)

Health system strengthening

Financing options

21/04/23

Page 5: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance

Pricing: MeTA Country Achievements

Country/MeTA Initiatives Impact/Achievement

Pricing/Availability studies conducted in different sectors (Ug,Zam)

- Stock outs highlighted- Differences in Public/Private sectors - Trends in availability highlighted- Recommendations made to justify

financing/health insurance- Wider dissemination of studies to other

sectors- Unaffordability highlighted

Development of Price Observatory (Peru) - Price transparency - Real time/on line data

Private Sector Mapping Survey conducted (Zam)

Revealed pricing structures of selected medicines in private sector

21/04/23

Page 6: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance

Pricing: MeTA Country Achievements

Country/MeTA Initiatives Impact/Achievement

Pricing survey for essential medicines to analyze prices in the decentralized hospital procurement system and private pharmacies. (KG)

-Expected to obtain pricing information in the various sectors to address improvement in policy

Review pharmacy and therapeutic committees constitution and terms of reference (JOR)

- include pharmacoeconomists and cost-effectiveness within those committees

Electronic essential drug price monitoring system from manufacturers to drug stores (PHL)

- Obtain actual prices along the distribution chain. Reference for procurement and index for re-imbursement.

21/04/23

Page 7: Medicines Transparency Alliance16/12/2015 Pricing: Observations Nazeem Mohamed Chairman, Uganda Pharmaceutical Manufacturers Association (UPMA) C.E.O

Medicines Transparency Alliance

Thank you

Nazeem Mohamed

Email: [email protected]

21/04/23